Veterinary Clinical Pathology · Consulting
Translational and toxicologic clinical pathology consulting for pharmaceutical development, CRO partnerships, and environmental health assessment.
Areas of Practice
Dr. Harr brings board-certified veterinary clinical pathology expertise to clients requiring rigorous data interpretation, regulatory-grade documentation, and translational insights across species and study types.
Clinical pathology support for IND-enabling and GLP toxicology studies across pharmaceutical and biotechnology programs.
Clinical pathology evaluation of free-ranging and managed wildlife populations exposed to environmental contaminants and stressors.
Design, validation, and quality oversight of diagnostic assays and laboratory programs in compliance with ASVCP guidelines and GLP requirements.
Independent expert review, scientific advisory support, and expert witness testimony for legal, regulatory, and investigative matters.
Diagnostic expertise in non-domestic species with particular depth in reptiles, amphibians, avian species, and marine mammals.
Pharmaceutical & CRO Services
From discovery through regulatory submission, Dr. Harr provides the board-certified oversight that CROs, biotech firms, and large pharmaceutical companies require to meet the highest standards of data quality and regulatory defensibility.
GLP and non-GLP toxicology study design, monitoring, and data interpretation for IND-enabling programs across rodent and non-rodent species.
De novo reference interval generation following ASVCP guidelines, including statistical analysis and species-specific considerations.
Novel biomarker and clinical chemistry assay validation, including precision, accuracy, and cross-platform comparability assessments.
Independent review of clinical pathology data packages, report sign-off, and regulatory submission support for FDA and international agencies.
Cross-species translational analysis linking preclinical pathology findings to clinical safety monitoring endpoints and patient risk assessment.
"Kendal's clinical pathology expertise would be an asset to any group. She has a large breadth of experience from academic, CRO, small biotech and large pharmaceutical companies."
— LinkedIn Recommendation, URIKA LLC
Dr. Harr has contributed directly to the regulatory guidance landscape as a member of the ASVCP Regulatory Affairs Committee, authoring best practice recommendations for veterinary toxicologic clinical pathology in pharmaceutical and biotechnology industries.
— Regulatory Background
Regulatory Familiarity
About
DVM, MS, Dipl. ACVP (Clinical) · Owner & Senior Pathologist, URIKA, LLC
Dr. Kendal Harr is a board-certified veterinary clinical pathologist with more than 25 years of experience spanning academic medicine, contract research organizations, and pharmaceutical and biotechnology consulting. She founded URIKA, LLC to provide independent, high-caliber clinical pathology services to clients who require expertise that goes beyond routine diagnostic support. Resume or CV available upon request.
Dr. Harr has been a consistent contributor to key texts and the guidelines that govern quality in veterinary clinical pathology. She co-authored the ASVCP allowable total error guidelines for biochemistry, the ASVCP reference interval guidelines, and multiple quality assurance frameworks now used by veterinary laboratories worldwide. Her work on regulatory best practices for toxicologic clinical pathology in pharmaceutical settings reflects the same commitment to defensible, reproducible science.
With more than 8,000 citations and 79 peer-reviewed publications and book chapters, Dr. Harr brings both scholarly depth and practical industry experience to every engagement. She has collaborated with clients ranging from small biotechs to global pharmaceutical corporations, and brings the same rigor and personal attention to each.
View Publication Record on Google Scholar →Credentials
DVM, MS, Dipl. ACVP (Clinical Pathology)
Training
Cornell University
University of Florida
Leadership
ASVCP Treasurer
QA & Lab Standards Chair (prev.)
Guidelines Author
Publications
79+ peer-reviewed publications & book chapters
Citations
8,000+
Experience
25+ years
Species Expertise
Effective translational pathology requires genuine expertise across the species used in research — not just rodents. Dr. Harr's diagnostic experience spans standard toxicology models and non-traditional research and wildlife species.
Get in Touch
Whether you are scoping a GLP toxicology study, need independent data review, or are developing a quality program for your laboratory, Dr. Harr welcomes direct inquiries from clients from diverse backgrounds.
Location
Washington, USA
Availability
Consulting engagements · Expert review · Advisory roles